CSIMarket
 
Contextlogic Holdings Inc   (LOGC)
 

LOGC's Market share relative to its competitors, as of Q4 2025

As of Q4 2025 (Revenue in Millions of $)

Date modified: 2026-07-18T11:00:18+00:00





COMPANY NAME REVENUES
12 Months Ending
Q4 2025
MARKET SHARE
12 Months
Q4 2025
MARKET SHARE
MRQ
Q4 2025
MARKET SHARE
A Quarter Before
Q3 2025
Contextlogic Holdings Inc 15.73 0.37% 0.17 % 0.35 %
Sarepta Therapeutics Inc 2,184.18 51.54% 46.30% 49.14%
Krystal Biotech Inc 417.30 9.85% 7.37% 11.88%
Immunocore Holdings Plc 412.81 9.74% 7.34% 11.84%
Beam Therapeutics Inc 164.01 3.87% 0.03% 3.52%
Poseida Therapeutics Inc 150.86 3.56% 4.55% 2.88%
28 more competitors available

Sign in to see all competitors for Contextlogic Holdings Inc .







Note: Market share is calculated based on total revenue. To get a more accurate picture of Contextlogic Inc's market divisions, geographic dispersion, segments, products, and services, visit Contextlogic Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.